HHLA2(B7H7) aAPC Cell
CBP74194
詢 價(jià)
索取Protocol
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
| I. Background | |
| HHLA2（也稱為 B7H5、B7H7 或 B7y）是 B7 家族的一員，它是 I 型跨膜蛋白，由具 有串聯(lián) IgV1-IgC-IgV2 結(jié)構(gòu)域的細(xì)胞外部分、跨膜區(qū)域和細(xì)胞質(zhì)尾部組成。HHLA2 低表達(dá) 于胎盤、腸道上皮細(xì)胞等，高表達(dá)于多種實(shí)體瘤（如肺癌、乳腺癌、結(jié)直腸癌、腎癌）及 炎癥微環(huán)境。HHLA2 具有雙向免疫調(diào)節(jié)功能：結(jié)合抑制性受體 KIR3DL3（NK 細(xì)胞）和未 知 T 細(xì)胞受體，傳遞抑制信號(hào)，減弱抗腫瘤免疫應(yīng)答；通過受體 TMIGD2 激活 PI3K-AKT 通路，促進(jìn) T 細(xì)胞存活及記憶形成。 | |
| II. Description | |
HHLA2(B7H7) aAPC Cell 作為 KIR3DL3 Effector Reporter Cell 或 TMIGD2 Effector Reporter Cell 的靶細(xì)胞 ， 很好的模擬了體內(nèi) KIR3DL3/ HHLA2(B7H7) 或TMIGD2/HHLA2(B7H7)的信號(hào)轉(zhuǎn)導(dǎo)過程，原理見下圖所示。  Figure 1. HHLA2(B7H7) aAPC Cell 細(xì)胞模型原理圖 |
|
| III. Introduction | |
| Expressed gene: | HHLA2(B7H7) |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | F12K+10%FBS+2μg/ml Puromycin+500μg/ml Hygromycin B |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| Application(s): | Functional(Report Gene) Assay |
| IV. Representative Data | |
|
Figure 2.Recombinant HHLA2(B7H7) aAPC Cell stably expressing HHLA2(B7H7). |
|
|
Figure 3. Dose Response of HHLA2 Blocking Abs in KIR3DL3 Effector Reporter Cell (C1) with HHLA2(B7H7) aAPC Cell(C1). |
|
|
Figure 4. Dose Response of HHLA2 Blocking Abs in TMIGD2 Effector Reporter Cell(C1) with HHLA2(B7H7) aAPC Cell. |
|
